Beam Therapeutics Inc. (BEAM) – it’s time to buy. Check out key Indicators
In yesterday’s Wall Street session, Beam Therapeutics Inc. (NASDAQ:BEAM) shares traded at $28.25, down -0.91% from the previous session. As of this writing, 15 analysts cover Beam Therapeutics Inc. (NASDAQ:BEAM). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $105.00 and a […]
